Since Bcl-xL is an NF-κB target gene [47], this may explain the mechanism of Bcl-xL suppression by RCAN1. PKA is reported to hyperphosphorylate Bcl-2 leading to a proteasome-mediated degradation in breast cancer cell lines [48]. Here, BCL2 is linked to breast carcinoma.